Cure My Disease

Don't miss your cure!

 Log in / Sign up

AI coach for throat scopes: could a computer help new doctors learn faster?

NCT ID NCT07726641

Knowledge-focused Sponsor: Ruijin Hospital Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 24, 2026 · Last updated Jul 24, 2026

Summary

This trial tests whether an artificial intelligence system can improve training for novice physicians learning electronic nasopharyngolaryngoscopy, a procedure to examine the throat and voice box. The AI monitors the procedure in real time, highlighting which anatomical areas have been checked. Researchers will compare the performance of doctors trained with the AI assistant against those trained conventionally, using expert ratings of recorded procedures.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Artificial Intelligence-Assisted Monitoring System for Electronic Nasopharyngolaryngoscopy
What this could lead to
If effective, this AI tool could speed up training for novice physicians, improving skill acquisition and patient safety in ear, nose, and throat procedures.
What could go wrong
This is a small, single-center study. The AI tool is only an adjunct and may not significantly outperform conventional training. Real-world effectiveness remains unproven.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 138 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jul 2026

An estimate. Start dates often move.

Expected to finish

Feb 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Eligibility Criteria for Novice Physicians： Inclusion Criteria * Aged 18 years or older. * Otorhinolaryngology residents or standardized residency training physicians. * No prior independent experience in electronic nasopharyngolaryngoscopy. * Holding both a physician qualification certificate and a physician practice certificate registered at the study institution. * Willing to participate in the study and provide written informed consent. Exclusion Criteria * Previous participation in other endoscopy training studies. * Inability to complete the required continuous training period Eligibility Criteria for Patient Participants： Inclusion Criteria * Aged 18 years or older. * Male or female. * Clinical need for electronic nasopharyngolaryngoscopy. * Able and willing to provide written informed consent. Exclusion Criteria * Pregnancy. * History of allergy to topical anesthetics such as tetracaine or lidocaine. * Language or communication barriers. * Anatomical abnormalities, such as laryngeal stenosis, or prior nasopharyngeal or laryngeal surgery. * Inability to tolerate the examination position. * Any condition judged by the investigator to make the participant unsuitable for the study.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Laryngoscopy are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Laryngoscopy Training

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai

    Shanghai, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.